The challenge of targeting metastasis

Isaiah J Fidler1, Margaret L Kripke2

  • 1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 173, Houston, TX, 77030, USA. ifidler@mdanderson.org.

Cancer Metastasis Reviews
|September 3, 2015
PubMed

Insights

Metastasis is a major cause of cancer death, often occurring before diagnosis. Targeting tumor cell and host interactions offers synergistic effects against existing, therapy-resistant metastases.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunotherapy

Background:

  • Metastasis is the primary cause of cancer-related mortality.
  • Therapy-resistant metastases are prevalent at diagnosis, limiting prevention strategies.
  • Tumor cell heterogeneity complicates treatment of metastatic disease.

Purpose of the Study:

  • To explore therapeutic strategies targeting the interactions between tumor cells and host homeostatic mechanisms.
  • To investigate synergistic effects of targeting both tumor cells and their microenvironment.

Main Methods:

  • Analysis of tumor cell-host interactions in metastatic contexts.
  • Evaluation of combined therapeutic approaches targeting tumor cells and host factors.

Main Results:

  • Tumor growth and survival are critically dependent on host interactions.
  • Targeting these interactions alongside tumor cells enhances therapeutic efficacy.
  • Synergistic effects observed in preclinical models of metastatic cancer.

Conclusions:

  • Interactions between tumor cells and host mechanisms are crucial for metastasis survival.
  • Combined therapeutic targeting of tumor cells and host interactions shows promise.
  • This approach may overcome resistance to conventional cancer therapies.